the future is now in mds: integrating innovative, risk-adapted therapies into patient management
Published 1 year ago • 432 plays • Length 1:35:54Download video MP4
Download video MP3
Similar videos
-
23:01
pre-clinical and clinical evaluation of autonomic function
-
12:22
advancing allieds: setting up atrial fibrillation (af) clinic
-
2:16
how does the trend of af burden guide your clinical treatment decisions?
-
1:16:58
what are my options with high risk mds aml
-
2:16
current and future treatment approaches for hr-mds
-
45:38
clinical trials and research updates in neuromuscular care
-
4:41
fda approved akt inhibitor for patients with advanced hr-positive breast cancer
-
1:02:28
treatment update: myelodysplastic syndromes (mds)
-
7:52
what does the future hold for patients with relapsed aml?
-
41:57
new research & clinical trials
-
8:30
case study - new guideline recommendations into clinical practice for the patient with af
-
47:01
advancing the management of mds and aml: novel immune-based approaches
-
1:41
the role of antibody-based therapies in mds treatment
-
1:17
bradley ruff, md
-
1:28
cd47 antibodies for the treatment of aml and mds: where is the field moving?
-
1:06
shatha farhan, md - medical oncology & hematology, henry ford health system
-
1:31:47
focus on understanding clinical trials and how to identify the right one for you
-
0:18
fda approves antibody treatment for emergency use
-
3:02
what is persistent dme and what treatment options do patients have regarding eye care? | eye news tv
-
2:12
midostaurin for newly diagnosed flt3 aml: radius-x efficacy and safety data
-
1:41
the future of aml and mds diagnosis and treatment
-
1:58
jad al danaf, md - cardiology